RenovaCare, Inc. operates as a development stage company, which engages in the research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues, and a solution sprayer device for delivering cells to the treatment area. The company was founded on July 14, 1983 and is headquartered in Scottsdale, AZ.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company